Biomarker analysis in oral levosimendan phase 2 clinical trial LEVALS

Category Primary study
JournalAmyotrophic Lateral Sclerosis and Frontotemporal Degeneration
Year 2019
This article has no abstract
Epistemonikos ID: 3b3288a935bab2e22e21724568c90a2f3f1a8172
First added on: Feb 11, 2025